Company intelligence / Profile preview
4P-Pharma
Lille, Hauts-de-France, France4p-pharma.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Phase 2
01
Overview
The lead asset, a GLP‑1 analog for osteoarthritis, has demonstrated anti-inflammatory, anti-catabolic, and anabolic properties. The company is entering Phase II clinical trials with this disease-modifying osteoarthritis drug. Other pipeline assets are in early clinical or preclinical stages targeting serious diseases with high unmet needs.[5][3][1]
- Therapeutic areas
- PulmonologyNephrologyRheumatologyOphthalmologyOncology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)BiosimilarsChemical drugs[4]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with academic research labs including St-Antoine’s Hospital/APHP/Sorbonne University and SATT Lutechseeking partnerships with AI tech companies for R&D sourcing.[3][5]
Beyond the preview
Go deeper on 4P-Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4P-Pharma.